2017 Senate Bill 47 / Public Act 252

Revise drug prescription reporting rules

Introduced in the Senate

Jan. 18, 2017

Introduced by Sen. Dale Zorn (R-17)

To revise a law that requires doctors and pharmacists to report all schedule 2, 3, 4, and 5 controlled substances that they prescribe and dispense to the state through an electronic reporting system. The bill would revise exemptions for drugs prescribed to an inpatient in a hospital setting, or in limited quantities by a health facility or agency.

Referred to the Committee on Health Policy

June 7, 2017

Reported without amendment

With the recommendation that the substitute (S-4) be adopted and that the bill then pass.

June 22, 2017

Passed in the Senate 36 to 1 (details)

Received in the House

July 12, 2017

Referred to the Committee on Health Policy

Oct. 4, 2017

Reported without amendment

With the recommendation that the substitute (H-2) be adopted and that the bill then pass.

Dec. 13, 2017

Passed in the House 104 to 6 (details)

To revise a law that requires doctors and pharmacists to report all schedule 2, 3, 4, and 5 controlled substances that they prescribe and dispense to the state through an electronic reporting system. The bill would revise exemptions for drugs prescribed to an inpatient in a hospital setting, or in limited quantities by a health facility or agency.

Received in the Senate

Dec. 13, 2017

Passed in the Senate 36 to 1 (details)

To concur with the House-passed version of the bill.

Signed by Gov. Rick Snyder

Dec. 27, 2017